Legend Biotech LEGN
NASDAQ LEGN
$21.52 -0.23 (-1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Legend Biotech (LEGN) Operating Margin Growth (3y) (2025 - 2026)

Analysis

Legend Biotech (LEGN) Operating Margin Growth (3y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -204.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 7,045.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -1,934.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7,261.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 9,003.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -2,649.00
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 30,461.00
10 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn -20,903.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20,903.00
Mar 31, 2026 -31,304.00
Dec 31, 2025 -41,213.00
Sep 30, 2025 -48,985.00